In the CCM group, inhibition of FGFR, HIF1α, or ITGB1 each led to decreased IL‐8 levels, with FGFR and ITGB1 suppression exerting the strongest effects (Figure 2D,E). Here, ITGB1 is linked to cerebral cavernous malformation.